Found: 10
Select item for more details and to access through your institution.
High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.727300
- By:
- Publication type:
- Article
SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 7, p. 1, doi. 10.1002/cti2.1306
- By:
- Publication type:
- Article
Innate lymphoid cell composition associates with COVID‐19 disease severity.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 12, p. 1, doi. 10.1002/cti2.1224
- By:
- Publication type:
- Article
MAIT cell activation and dynamics associated with COVID-19 disease severity.
- Published in:
- Science Immunology, 2020, v. 5, n. 51, p. 1, doi. 10.1126/sciimmunol.abe1670
- By:
- Publication type:
- Article
Proteomic characterization of the normal human medial meniscus body using data‐independent acquisition mass spectrometry.
- Published in:
- Journal of Orthopaedic Research, 2020, v. 38, n. 8, p. 1735, doi. 10.1002/jor.24602
- By:
- Publication type:
- Article
Natural killer cell immunotypes related to COVID-19 disease severity.
- Published in:
- Science Immunology, 2020, v. 5, n. 50, p. 1, doi. 10.1126/sciimmunol.abd6832
- By:
- Publication type:
- Article
Differential protein expression in human knee articular cartilage and medial meniscus using two different proteomic methods: a pilot analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.
- Published in:
- PLoS Neglected Tropical Diseases, 2017, v. 11, n. 6, p. 1, doi. 10.1371/journal.pntd.0005545
- By:
- Publication type:
- Article
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
- Published in:
- 2016
- By:
- Publication type:
- journal article